Release of the Novel Coronavirus Detection Kit for Wipe Tests Allows quick and easy detection of the novel coronavirus on touch screens, doorknobs, etc. for efficient health and safety management

February 22, 2021 The Novel Coronavirus Detection Kit for Wipe Tests Shimadzu Corporation has released the Novel Coronavirus Detection Kit for Wipe Tests. This reagent kit detects the novel coronavirus on surfaces quickly, easily, and with high sensitivity via the PCR test method. It is intended for use in hygiene management and health and safety... Read more

PerkinElmer Launches Industry-First GPCR TR-FRET Binding Assay and Beta-Arrestin Kits to Help Advance Therapeutics Discovery

New offerings join PerkinElmer’s leading GPCR Portfolio across characterization and screening assays, screening libraries and workflow optimization WALTHAM, Mass. – January 26, 2021 –PerkinElmer, a global leader committed to innovating for a healthier world, today announced the addition of new assay kits to help further GPCR      (G Protein-Coupled Receptor) therapeutic discovery. The new PerkinElmer offerings... Read more

Sales of Novel Coronavirus PCR Testing Reagent Kits outside Japan Exports Began

January 21, 2021 Shimadzu Corporation will begin fully rolling out sales of the novel coronavirus (SARS-CoV-2) detection reagent kits outside Japan. On January 19th, Shimadzu obtained provisional authorization from the Singapore Health Sciences Authority (HSA) to sell the kits and will start exporting the kits to Southeast Asian markets through Shimadzu (Asia Pacific) Pte. Ltd.,... Read more

Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex

WALTHAM, Mass., Dec. 31, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research.... Read more

PerkinElmer Launches MaxSignal™ HTS Total Aflatoxins and DON ELISA Kits with Advanced Automation for Streamlined Mycotoxin Testing

Solution designed for complex matrices, delivering high sensitivity, single sample prep and high throughput processing   WHAT:   PerkinElmer , a global leader committed to innovating for a healthier world, today announced its MaxSignal™ HTS Total Aflatoxins and DON ELISA Kits featuring automated Read more

Targeted sequencing with Oxford Nanopore: Fast, flexible, PCR-free Cas9 Sequencing Kit now available in store

Wed 16th September 2020 New Cas9 Sequencing Kit provides reagents for one-stop targeted sequencing, enabling scientists to cost-effectively sequence previously inaccessible target regions. Cas9 targeted sequencing with nanopore enables fast, simple, flexible target enrichment of long regions of interest – read lengths of over 100 kb have been observed to date. The approach is amplification-free, opening up regions... Read more

PerkinElmer Launches COVID-19 Environmental Surface Testing Kits to Help Food Processors and Contract Labs Detect Presence of Virus in Facilities

Kits detect traces of SARS-CoV-2 virus on surfaces such as plastics, ceramics and stainless steel  WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today introduced two COVID-19 environmental testing kits to help food processors and contract labs detect the presence of SARS-CoV-2 on surfaces in food plants such as plastic, ceramic... Read more

96 barcodes: Expanded PCR-free multiplexing capacity for lower cost per sample – now available in store

Thu 21st May 2020 Latest kit release provides 96 native barcodes for PCR-free sequencing, allowing higher numbers of samples to be run on a single flow cell – including for SARS-CoV-2 whole genome sequencing protocol. The Native Barcoding Expansion (96) kit is available to purchase on the Store now here. Oxford Nanopore provides direct sequencing of... Read more

QIAGEN dramatically ramping up global production capacity for RNA extraction kits for use in detection of SARS-CoV-2 coronavirus

Hilden, Germany, and Germantown, Maryland, March 17, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to dramatically ramp up global production capacity of RNA extraction kits that are used as part of workflows around the world to detect nucleic acid from SARS-CoV-2, the novel coronavirus that causes COVID-19. QIAGEN has historically... Read more